EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Holding On or Letting Go: Immunosuppression After Pediatric Kidney Allograft Failure

Nicole Hayde iD, Nancy Rodig iD, Saritha Ranabothu iD, Olga Charnaya iD

Pediatric Transplantation · 2026-06 · 30 (6)

DOI: 10.1111/petr.70340 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Transplantation, online erschienen am 27.05.2026. Verfasst von Nicole Hayde und 3 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital at Montefiore, Bronx, New York, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppression Therapy, Immunosuppressive Agents, Graft Rejection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney allograft failure is a devastating event often marked by return to dialysis and is associated with increased morbidity and mortality. Given the young age at transplant for pediatric recipients, they are likely to require retransplantation during their lifetime. Optimal immunosuppression (IS) management in the setting of a failing allograft is crucial to preserve residual renal function, prevent graft intolerance, and limit the development of anti‐HLA antibodies. The management of IS during allograft failure is highly variable between providers and reflects the paucity of data to guide clinical decision‐making. In addition, pediatric recipients have shorter waiting times for kidney transplants due to priority allocation for deceased donors compared to adult candidates, suggesting that current protocols may not be generalizable to pediatric kidney recipients with allograft failure. In this review we summarize the extent of current recommendations, identify limitations as they pertain to pediatric patients, and provide recommendations for vitally needed future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationImmunosuppression TherapyImmunosuppressive AgentsGraft RejectionHumansChildAllografts

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Children's Hospital at Montefiore, Bronx, New York, USA.
  • Boston Children's Hospital, Boston, Massachusetts, USA.
  • Arkansas Children's Hospital, University of Arkansas Medical Sciences, Little Rock, Arkansas, USA.
  • Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Nicole Hayde, Nancy Rodig, Saritha Ranabothu, Olga Charnaya

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Hayde, N., Rodig, N., Ranabothu, S., & Charnaya, O. (2026). Holding On or Letting Go: Immunosuppression After Pediatric Kidney Allograft Failure. Pediatric Transplantation, 30(6). https://doi.org/10.1111/petr.70340

Vancouver

Hayde N, Rodig N, Ranabothu S, Charnaya O. Holding On or Letting Go: Immunosuppression After Pediatric Kidney Allograft Failure. Pediatric Transplantation. 2026;30(6). doi:10.1111/petr.70340

BibTeX
@article{Hayde2026,
  author = {Hayde, Nicole and Rodig, Nancy and Ranabothu, Saritha and Charnaya, Olga},
  title = {Holding On or Letting Go: Immunosuppression After Pediatric Kidney Allograft Failure},
  journal = {Pediatric Transplantation},
  year = {2026},
  volume = {30},
  number = {6},
  doi = {10.1111/petr.70340}
}
Kostenlos starten →